The effects of colchicine on secretion into bile of bile salts, phospholipids, cholesterol and plasma membrane enzymes: bile salts are secreted unaccompanied by phospholipids and cholesterol

• Published in: Biochemical journal Vol. 220; no. 3; pp. 723 - 731
• Main Authors: Barnwell, S G, Lowe, P J, Coleman, R
• Format: Journal Article
• Language: English
• Published: England 15-06-1984
• Subjects: Animals; Bile - drug effects; Bile - enzymology; Bile - metabolism; Bile Acids and Salts - metabolism; bile salts; Biological Transport - drug effects; Cell Membrane - enzymology; cholesterol; Cholesterol - metabolism; colchicine; Colchicine - pharmacology; liver; Liver - metabolism; Male; Perfusion; phospholipids; Phospholipids - metabolism; plasma membranes; Rats; Rats, Inbred Strains
• ISSN: 0264-6021; 1470-8728
• DOI: 10.1042/bj2200723

Colchicine, a drug which interferes with microtubular function, has no effect on the secretion of taurodehydrocholate into bile; it is therefore suggested that bile salts are unlikely to be packaged in vesicles during cellular transit from sinusoidal to canalicular membranes. Colchicine greatly reduces the secretion of phospholipid and cholesterol into bile; it is suggested that this is due to an interruption in the supply of vesicles bringing lipids to repair the canalicular membrane during bile salt output. In the absence of the protective effect of a continuous supply of repair vesicles, micelleforming bile salts damage the canalicular membrane; the increased concentration of plasma membrane enzymes in bile and the increased aspartate aminotransferase activity in plasma and bile are evidence of this damage. Damage to the canalicular membrane may also be an explanation for the reduction in taurocholate transport and the taurocholate-induced cholestasis which are seen with colchicine-treated livers. Such membrane damage is not observed in colchicine-treated livers during the secretion of the non-micelle forming bile salt, taurodehydrocholate.